Recent PBYI News
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 07/02/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:27:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:25:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:23:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:18:53 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/14/2024 01:46:47 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/14/2024 01:44:55 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/14/2024 01:43:51 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/14/2024 01:41:17 AM
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 06/07/2024 09:37:00 PM
- Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer • Business Wire • 06/03/2024 06:33:00 PM
- Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041) • Business Wire • 06/02/2024 02:01:00 PM
- Puma Biotechnology to Join Russell 3000 Index • Business Wire • 05/28/2024 01:00:00 PM
- Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting • Business Wire • 05/23/2024 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:43:17 PM
- Puma Biotechnology Reports First Quarter Financial Results • Business Wire • 05/02/2024 08:05:00 PM
- Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results • Business Wire • 04/18/2024 08:15:00 PM
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 04/03/2024 09:30:00 PM
- Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer • Business Wire • 03/20/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:16:09 PM
- Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 02/29/2024 09:05:00 PM
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 02/27/2024 11:30:00 PM
- Puma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care Conference • Business Wire • 02/22/2024 09:10:00 PM
- Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 02/15/2024 09:10:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 11:03:11 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM